This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.
Medical and biotech had a strong showing at Y Combinator’s latest demo day , with nearly a dozen companies in the space catching my eye. LiliumX is taking the algorithmic approach to generating potential antibody stuctures that could be effective, as many AI-informed biotech companies have before it. Startups take on big pharma.
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”
This allows product developers to review and discuss 3D models in more than 30 file formats in real time. Nicolai Peitersen, co-founder and executive chairman of Wikifactory said: “Wide-scale global collaboration to make physical things is happening both for open-source and for proprietary product development.
3D illustration. Any one of these vastly different organisms may very well have developed on its own a novel chemical pathway that could transform food production, drug manufacturing or agriculture. And Hexagon Bio also recently raised on a similar proposition of locating naturally occurring molecules for use in drug development.
iRocket is earmarking $50 million over the next five years for the testing and development of its reusable engines and launch vehicle. Manufactured via 3D printing, the engines will be powered by methane and liquid oxygen. and 1,500 kg (around 3,300 lbs.). Methane is going to be the fuel of choice for deep space missions,” Malik said.
For annotating complex 3D medical images, it also has semi-automated tools. The startup also sees 99% of competition coming from open-source tools, followed by the in-house ones developed by companies to address their specific requirements. and Europe for marketing its tools.
Department of Energy ’s Milestone-Based Fusion Development Program. tied) Prolific Machines , $55M, biotech: Unlike in previous weeks, there was no huge biotech round. The startup plays at a unique intersection of healthcare/biotech, AI and 3D technology. Founded in 2020, Prolific has raised $86.5
Rather than launching brands, these are B2B alternative protein companies developing scalable industrial production platforms. Mooji Meats: Speedy 3D printing whole cuts. The company has developed a 3D printer capable of producing whole cuts of meat using plant protein or cultured meat cells. million seed round.
Similarly, clothing brand Under Armour recently produced an ad that used AI-generated 3D models of the British boxer Anthony Joshua, based on videos they took of him in the past. Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO.
Discovery and research of new molecular compounds is an expensive business, with development costs exceeding $10 billion per substance in some cases. Nanome streamlines this process by bringing researchers to the same virtual reality space to work on molecule development together. per drug.”.
Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.
Four of the new unicorns this past month were under 3 years old at the time they were valued at or above $1 billion with one — a foundation model developer for robotics — launching out of stealth. Healthcare/biotech companies took the lead with three companies that joined the board from this sector.
Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. million Series B round on Wednesday. Some are computational.
A standard IVF process involves transferring cells to different environments in a petri dish as an embryo develops. ” Fertilis’s solution is to standardize and automate the IVF process by putting each embryo in its patented 3D-printed cradle. . Fertilis’s new funding will support its ongoing scientific development.
With all the venture funding in biotech , it is no surprise that one of the largest deals was Merck ’s acquisition of New York-based eye disease therapy company Eyebiotech. For those acquirers, sectors have included cloud management, AI tooling, security and asset management and content development platforms.
The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. A lot of focus is on life sciences, biotech, as there is a lot of research at the Utrecht science park and also spin-offs. We could do with a bit stronger IT education (developers!).
Some think such a development could be the next advancement of AI, since human neurons have some advantages over their digital counterparts. Neura is developing the robot and others for a wide range of industries and already has partners in multiple sectorsn that include manufacturing, hospitality and elder care.
The company continued hiring developers and marketers and raised the team by around 10%. Developed a SaaS-based white-label web3 platform that opens revenue streams and strengthens community engagement. Ahrefs claims to have become a $100 million company in annual revenue without venture capital. Incorporated in Delaware, USA.
It also led the $43 million Series B for Palo Alto, California-based Luma , which helps users develop3D models using AI, and co-led voice AI startup ElevenLabs ’ $80 million Series B at a unicorn valuation as investor interest in all AI tech remains at an all-time high. Andressen Horowitz didn’t stop there with AI.
The startup has developed phytosterol-based solutions to help plants adapt better to climate change. The Singapore-based startup aims to create a world where human and AI interactions are seamless, enriched and democratic, building augmented social experiences through multimodal AI, including 3D modeling.
tied) Second Dinner , $100M, gaming: It’s rare that a game developer comes up this high on the list , but Second Dinner locked up a top spot with a $100 million Series B led by Griffin Gaming Partners this week. Founded in 2007, the company has raised nearly $162 million, per Crunchbase. Big global deals Despite some big raises in the U.S.,
3D modeling . New York’s 3D printing community is considered the largest in the world. According to July 2016 data from 3D Hubs, New York was home to 3,739 makers and 516 3D printers, far ahead of second-place L.A., Leading companies include Shapeways, 3D Brooklyn, 3D Hubs, and Voodoo Manufacturing.
The Singapore-based startup aims to create “a world where human and AI interactions are seamless, enriched and democratic,” building augmented social experiences through multimodal AI, including 3D modeling. We know 1X is only one of several humanoid developers. Making therapies better and more accessible will be vital moving forward.
If this seems too long and complex, just make a comparison with a drug development process. Drug discovery is the first stage of the drug development flow that pinpoints new substances with strong potential to fight a targeted disease. On average, only one of 25 leads is pushed for further development. Drug development process.
Being a dedicated development team provider for over a decade, Mobilunity has embraced many aspects of Business Process Outsourcing. With the rise of globalization and industrialization, businesses have used external firms to decrease expenses and focus on innovation and product development. Development services.
Printing me softly with his song : Mostly known for its battery packs, Anker launches a Kickstarter campaign for its first 3D printer. 6 questions investors should ask when evaluating psychedelic biotech companies. 6 questions investors should ask when evaluating psychedelic biotech companies. You can sign up here.).
“These two are a powerhouse team who have the ability to completely shift our understanding of modern genetics while developing innovative technologies that not only help bring back lost species, but advance the entire industry,” Robbins tells TechCrunch. “I This is a 3D render illustration. Mammoth in the middle of mountains.
Medical technology or MedTech may include medical devices, information technology, biotech, and healthcare services. When looking specifically at the MedTech industry, 3D printing has quickly become one of the most popular technologies for new startups as well as established corporations. 3-D Printing. DNA Script. FibriCheck.
It has also developed its own product: a “tampliner”, which is a tampon and a liner in one. The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps as an alternative to traditional painkillers. The company has raised $26m from a number of biotech investors. It has raised €7.3m
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content